- Home
- MDBH vs IGC Comparison
MDBH vs IGC Comparison
Compare MDBH & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDBH
- IGC
- Stock Information
- Founded
- MDBH 1997
- IGC 2005
- Country
- MDBH United States
- IGC United States
- Employees
- MDBH N/A
- IGC N/A
- Industry
- MDBH
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- MDBH
- IGC Health Care
- Exchange
- MDBH Nasdaq
- IGC Nasdaq
- Market Cap
- MDBH 38.2M
- IGC 31.0M
- IPO Year
- MDBH 2023
- IGC N/A
- Fundamental
- Price
- MDBH $3.40
- IGC $0.37
- Analyst Decision
- MDBH
- IGC Strong Buy
- Analyst Count
- MDBH 0
- IGC 2
- Target Price
- MDBH N/A
- IGC $3.88
- AVG Volume (30 Days)
- MDBH 5.8K
- IGC 732.2K
- Earning Date
- MDBH 08-27-2025
- IGC 08-14-2025
- Dividend Yield
- MDBH N/A
- IGC N/A
- EPS Growth
- MDBH N/A
- IGC N/A
- EPS
- MDBH 0.56
- IGC N/A
- Revenue
- MDBH N/A
- IGC $1,327,000.00
- Revenue This Year
- MDBH N/A
- IGC $15.26
- Revenue Next Year
- MDBH N/A
- IGC $3.41
- P/E Ratio
- MDBH $5.82
- IGC N/A
- Revenue Growth
- MDBH N/A
- IGC 24.95
- 52 Week Low
- MDBH $3.21
- IGC $0.25
- 52 Week High
- MDBH $9.68
- IGC $0.48
- Technical
- Relative Strength Index (RSI)
- MDBH 35.36
- IGC 56.73
- Support Level
- MDBH $3.35
- IGC $0.35
- Resistance Level
- MDBH $4.28
- IGC $0.37
- Average True Range (ATR)
- MDBH 0.15
- IGC 0.02
- MACD
- MDBH -0.06
- IGC 0.00
- Stochastic Oscillator
- MDBH 19.27
- IGC 69.17
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.